Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingxin Pang

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Oncotargets and Therapy|May 3, 2014
MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAPYingxin Pang, Hongluan Mao, Liang Shen, et al.
Journal of Hazardous Materials|November 12, 2024
Copper oxide nanoparticles induce non-alcoholic fatty liver disease by disrupting bile acid homeostasis and perturbing the intestinal microbial homeostasisMuran Jiang, Xiaoqi Tao, Yingxin Pang, et al.
Toxicology Letters|June 8, 2024
Chiral silver nanoparticles with surface-anchored L(D)-Cys exhibit dissimilar biological characteristics in vitro but not in vivoYingxin Pang, Xiaoqi Tao, Zongmin Qin, et al.
Analytical Chemistry|February 4, 2025
Antiprotein Corona-Fouling Effect of the Double-Stranded DNA Coating Layer on the Gold Nanoparticles-Small Molecule Adsorbent ProbeZongming Qin, Xiaoqi Tao, Yingxin Pang, et al.
Archives of Gynecology and Obstetrics|March 19, 2020
Clinicopathological factors and prognosis analysis of 39 cases of non-gestational ovarian choriocarcinomaXiaodie Liu, Xue Zhang, Yingxin Pang, et al.
BMC Women'S Health|June 27, 2024
When synchronous mucinous metaplasia and neoplasia of the female genital tract and peutz-jeghers syndrome meet: a case report and literature reviewsYue Zhou, Xinyi Wang, Yang Li, et al.
Frontiers in Genetics|January 27, 2023
The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefitYue Hou, Sijing Qiao, Miao Li, et al.
Medicine|October 30, 2020
A comparison between laparoscopy and hysteroscopy approach in treatment of cesarean scar pregnancyXiaolei Zhang, Yingxin Pang, Yanhui Ma, et al.
Oncotargets and Therapy|July 2, 2020
Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivoXiaolei Zhang, Tao Lu, Yanhui Ma, et al.
Archives of Gynecology and Obstetrics|November 27, 2014
Celecoxib induces epithelial-mesenchymal transition in epithelial ovarian cancer cells via regulating ZEB1 expressionRuihan Liu, Jingfang Zheng, Chao Li, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Oncotargets and Therapy|May 3, 2014
MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAPYingxin Pang, Hongluan Mao, Liang Shen, et al.
Journal of Hazardous Materials|November 12, 2024
Copper oxide nanoparticles induce non-alcoholic fatty liver disease by disrupting bile acid homeostasis and perturbing the intestinal microbial homeostasisMuran Jiang, Xiaoqi Tao, Yingxin Pang, et al.
Toxicology Letters|June 8, 2024
Chiral silver nanoparticles with surface-anchored L(D)-Cys exhibit dissimilar biological characteristics in vitro but not in vivoYingxin Pang, Xiaoqi Tao, Zongmin Qin, et al.
Analytical Chemistry|February 4, 2025
Antiprotein Corona-Fouling Effect of the Double-Stranded DNA Coating Layer on the Gold Nanoparticles-Small Molecule Adsorbent ProbeZongming Qin, Xiaoqi Tao, Yingxin Pang, et al.
Archives of Gynecology and Obstetrics|March 19, 2020
Clinicopathological factors and prognosis analysis of 39 cases of non-gestational ovarian choriocarcinomaXiaodie Liu, Xue Zhang, Yingxin Pang, et al.
BMC Women'S Health|June 27, 2024
When synchronous mucinous metaplasia and neoplasia of the female genital tract and peutz-jeghers syndrome meet: a case report and literature reviewsYue Zhou, Xinyi Wang, Yang Li, et al.
Frontiers in Genetics|January 27, 2023
The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefitYue Hou, Sijing Qiao, Miao Li, et al.
Medicine|October 30, 2020
A comparison between laparoscopy and hysteroscopy approach in treatment of cesarean scar pregnancyXiaolei Zhang, Yingxin Pang, Yanhui Ma, et al.
Oncotargets and Therapy|July 2, 2020
Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivoXiaolei Zhang, Tao Lu, Yanhui Ma, et al.
Archives of Gynecology and Obstetrics|November 27, 2014
Celecoxib induces epithelial-mesenchymal transition in epithelial ovarian cancer cells via regulating ZEB1 expressionRuihan Liu, Jingfang Zheng, Chao Li, et al.
Pageof 4